Skip to content

CARBOMEDICS CARBO-SEAL VALSALVA CP-027Recalls & reported problems

Corcym Srl · Class 3 · Implant

All models of CARBOMEDICS CARBO-SEAL VALSALVA (5)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
4
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 08022057013569), received between Nov 20, 2017 and Dec 28, 2023 — classified as 4 injuries.

The most frequently reported specific device problem is “Insufficient Device Problem Information” (3 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 2 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Insufficient Device Problem Information3
  • Adverse Event Without Identified Device or Use Problem1
  • Defective Component1
  • Leak/Splash1

Patient problems

  • Insufficient Information2
  • Connective Tissue Disease1
  • No Information1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 28, 2023Insufficient Device Problem Information; Insufficient Device Problem Information

    MANUFACTURER WAS INFORMED OF THE FOLLOWING EVENT THROUGH DEVICE TRACKING DEPARTMENT. REPORTEDLY, ON (B)(6) 2012, A CARBOSEAL VALSALVA VALVE CP-029 WAS IMPLANTED IN A PATIENT. THE DEVICE WAS EXPLANTED AND REPLACED WITH A PERCEVAL VALVE PVS27 ON (B)(6)2017. NO ALLEGATION OF ANY DEVICE DYSFUNCTION OR SERIOUS INJURY ON THE PATIENT HAS YET BEEN REPORTED FROM THE SITE.

    Patient problems: Insufficient Information

    MAUDE report 18416333 ↗
  • InjuryDec 28, 2023Insufficient Device Problem Information; Insufficient Device Problem Information

    MANUFACTURER WAS INFORMED OF THE FOLLOWING EVENT THROUGH DEVICE TRACKING DEPARTMENT. REPORTEDLY, ON 14 JAN 2012, A CARBOSEAL VALSALVA VALVE CP-029 WAS IMPLANTED IN A PATIENT. THE DEVICE WAS EXPLANTED AND REPLACED WITH A PERCEVAL VALVE PVS27 ON (B)(6) 2017. NO ALLEGATION OF ANY DEVICE DYSFUNCTION OR SERIOUS INJURY ON THE PATIENT HAS YET BEEN REPORTED FROM THE SITE.

    Patient problems: Insufficient Information

    MAUDE report 18414630 ↗
  • InjuryApr 12, 2018Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information

    IT WAS REPORTED THAT A CARBOSEAL VALSALVA ASCENDING AORTIC PROSTHESIS WAS IMPLANTED ON (B)(6) 2017 AT THE AORTIC POSITION. ON (B)(6) 2018, A CROWN PRT VALVE WAS REPORTEDLY IMPLANTED AT THE SAME POSITION.

    Patient problems: No Information

    MAUDE report 7425593 ↗
  • InjuryNov 20, 2017Leak/Splash; Defective Component

    (B)(6) 2017, A CARBOSEAL VALSALVA 27 MM VALVE GRAFT WAS IMPLANTED FOR A BENTALL PROCEDURE. AFTER ALL ANASTOMOSES WERE COMPLETE, IT WAS FOUND THAT THE GRAFT WAS LEAKING AT THE JUNCTURE BETWEEN THE VALVE AND THE GRAFT. THE PHYSICIAN PLACED A STITCH IN THE AREA THAT THE GRAFT WAS LEAKING, BUT THE LEAKING CONTINUED. AFTER INSPECTING THE GRAFT, THE PHYSICIAN BELIEVED THE DEVICE TO BE DEFECTIVE AND REMOVED THE PRODUCT. A 30 MM TUBE GRAFT AND 23 MM TOP HAT MECHANICAL AORTIC VALVE WERE THEN IMPLANTED. THE PHYSICIAN REPORTED THAT, AFTER REMOVING THE CARBOSEAL, A SIMPLE TUBE GRAFT WAS SEWN AT THE ANNULAR LEVEL AND THE TOP HAT WAS SEWN INTO THE GRAFT ABOVE THE ANASTOMOSIS. THIS WAS DONE TO ENSURE THE ANASTOMOSIS WAS SECURE IN THE PATIENT'S FRAGILE TISSUE. THE PATIENT WAS A MARFAN'S PATIENT WITH FRIABLE TISSUE. THE SURGERY WAS DELAYED BY 4 HOURS AS A RESULT OF THE EVENT.

    Patient problems: Connective Tissue Disease

    MAUDE report 7047621 ↗

Other HEART-VALVE, MECHANICAL devices

All HEART-VALVE, MECHANICAL devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page